J Korean Med Sci.  2021 Dec;36(50):e343. 10.3346/jkms.2021.36.e343.

Are the Current Guidelines Sufficient to Establish Infection Control Strategies for COVID-19 Related Issues in Hospitals?

• Jang W
• Kim B
• Kim ES
• Song KH
• Moon SM
• Lee MJ
• Park JY
• Kim JY
• Shin MJ
• Lee H
• Kim HB

• KMID: 2523563
• DOI: http://doi.org/10.3346/jkms.2021.36.e343

Abstract

As hospitals cater to elderly and vulnerable patients, a high mortality rate is expected if a coronavirus disease 2019 (COVID-19) outbreak occurs. Consequently, policies to prevent the spread of COVID-19 in hospital settings are essential. This study was conducted to investigate how effectively national and international guidelines provide recommendations for infection control issues in hospitals. After selecting important issues in infection control, we performed a systematic review and analysis of recommendations and guidelines for preventing COVID-19 transmission within medical institutions at national and international levels. We analyzed guidelines from the World Health Organization, Centers for Disease Control and Prevention, European Centre for Disease Prevention and Control, and Korea Disease Control and Prevention Agency. Recent guidelines do not provide specific solutions to infection control issues. Therefore, efforts need to be made to devise consistent advice and guidelines for COVID-19 control.

Keyword

Coronavirus Disease 2019; Hospital; Infection Control; Guidelines

Reference

1. World Health Organization (WHO). Advice on the use of masks in the context of COVID-19: interim guidance. Updated 2020. Accessed May 14, 2021. https://apps.who.int/iris/handle/10665/332293 .

2. World Health Organization (WHO). Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19): interim guidance. Updated 2020. Accessed May 14, 2021. https://apps.who.int/iris/handle/10665/331215 .

3. World Health Organization (WHO). Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected: interim guidance. Updated 2020. Accessed May 14, 2021. https://www.who.int/publications/i/item/10665-331495 .

4. World Health Organization (WHO). Clinical management of COVID-19: interim guidance. Updated 2020. Accessed May 14, 2021. https://apps.who.int/iris/handle/10665/332196 .

5. World Health Organization (WHO). Criteria for releasing COVID-19 patients from isolation: scientific brief. Updated 2020. Accessed May 14, 2021. https://apps.who.int/iris/handle/10665/332451 .

6. Centers for Disease Control and Prevention (CDC). Interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic. Updated 2020. Accessed May 14, 2021. https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html .

7. Centers for Disease Control and Prevention (CDC). Return to work criteria for healthcare personnel with SARS-CoV-2 infection (interim guidance). Updated 2020. Accessed May 14, 2021. https://www.cdc.gov/coronavirus/2019-ncov/hcp/return-to-work.html .

8. Centers for Disease Control and Prevention (CDC). Interim U.S. Guidance for risk assessment and work restrictions for healthcare personnel with potential exposure to SARS-CoV-2. Updated 2020. Accessed May 14, 2021. https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html .

9. Centers for Disease Control and Prevention (CDC). Framework for healthcare systems providing non-COVID-19 clinical care during the COVID-19 pandemic. Updated 2020. Accessed May 14, 2021. https://www.cdc.gov/coronavirus/2019-ncov/hcp/framework-non-COVID-care.html .

10. Centers for Disease Control and Prevention (CDC). Performing broad-based testing for SARS-CoV-2 in congregate correctional, detention, and homeless service settings. Updated 2020. Accessed May 14, 2021. https://www.cdc.gov/coronavirus/2019-ncov/hcp/broad-based-testing.html .

11. Centers for Disease Control and Prevention (CDC). Interim guidance on testing healthcare personnel for SARS-CoV-2. Updated 2020. Accessed May 14, 2021. https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-healthcare-personnel.html .

12. Centers for Disease Control and Prevention (CDC). Responding to SARS-CoV-2 infections in acute care facilities. Updated 2020. Accessed May 14, 2021. https://www.cdc.gov/coronavirus/2019-ncov/hcp/responding-acute-care-facilities.html .

13. European Centre for Disease Prevention and Control. Infection prevention and control and preparedness for COVID-19 in healthcare settings. Updated 2020. Accessed May 14, 2021. https://www.ecdc.europa.eu/en/publications-data/infection-prevention-and-control-and-preparedness-covid-19-healthcare-settings .

14. Korea Disease Control and Prevention Agency (KDCA). Guidelines for the management of medical institutions with confirmed coronavirus infections-19 (for local government). Updated 2020. Accessed May 14, 2021. https://www.kdca.go.kr/board/board.es?mid=a20507020000&bid=0019 .

15. Korea Disease Control and Prevention Agency (KDCA). Coronavirus infectious disease-19 response guidelines (for medical institutions). Updated 2020. Accessed May 14, 2021. https://www.kdca.go.kr/board/board.es?mid=a20507020000&bid=0019 .

16. Korea Disease Control and Prevention Agency (KDCA). Guidance on the operation of a screening clinic for coronavirus infections. Updated 2020. Accessed May 14, 2021. https://www.kdca.go.kr/board/board.es?mid=a20507020000&bid=0019 .

17. Korea Disease Control and Prevention Agency (KDCA). Coronavirus infections-19 prevention and control of infections in medical institutions (for hospital-level medical institutions). Updated 2020. Accessed May 14, 2021. https://www.kdca.go.kr/board/board.es?mid=a20507020000&bid=0019 .

18. Kim JE, Lee JH, Lee H, Moon SJ, Nam EW. COVID-19 screening center models in South Korea. J Public Health Policy. 2021; 42(1):15–26. PMID: 33087849.

19. Shi HJ, Lee JB, Choi MK, Jang YR, Cho YK, Eom JS. Protection and response of a tertiary hospital in South Korea to the COVID-19 outbreak. Disaster Med Public Health Prep. 2021; 15(1):e1–e5.

20. Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med. 2020; 17(9):e1003346. PMID: 32960881.

21. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020; 323(14):1406–1407. PMID: 32083643.

22. Kim SE, Jeong HS, Yu Y, Shin SU, Kim S, Oh TH, et al. Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients. Int J Infect Dis. 2020; 95:441–443. PMID: 32376309.

23. Hanson KE, Caliendo AM, Arias CA, Hayden MK, Englund JA, Lee MJ, et al. Infectious diseases society of America guidelines on the diagnosis of COVID-19: molecular diagnostic testing. Updated 2020. Accessed September 27, 2021. https://www.idsociety.org/practice-guideline/covid-19-guideline-diagnostics/ .

24. Telford CT, Onwubiko U, Holland DP, Turner K, Prieto J, Smith S, et al. Preventing COVID-19 outbreaks in long-term care facilities through preemptive testing of residents and staff members - Fulton County, Georgia, March–May 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(37):1296–1299. PMID: 32941413.

25. Centers for Disease Control and Prevention (CDC). Ending isolation and precautions for people with COVID-19: interim guidance. Updated 2021. Accessed September 27, 2021. https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html .

26. Cheng HY, Jian SW, Liu DP, Ng TC, Huang WT, Lin HH, et al. Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset. JAMA Intern Med. 2020; 180(9):1156–1163. PMID: 32356867.

27. Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020; 581(7809):465–469. PMID: 32235945.

28. Bullard J, Dust K, Funk D, Strong JE, Alexander D, Garnett L, et al. Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples. Clin Infect Dis. 2020; 71(10):2663–2666. PMID: 32442256.

29. Arons MM, Hatfield KM, Reddy SC, Kimball A, James A, Jacobs JR, et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med. 2020; 382(22):2081–2090. PMID: 32329971.

30. Liu WD, Chang SY, Wang JT, Tsai MJ, Hung CC, Hsu CL, et al. Prolonged virus shedding even after seroconversion in a patient with COVID-19. J Infect. 2020; 81(2):318–356.

31. Korea Centers for Disease Control & Prevention Division of Risk Assessment and International Cooperation. Findings from investigation and analysis of re-positive cases. Updated 2020. Accessed September 27, 2021. https://www.cdc.go.kr/board/board.es?mid=a30402000000&bid=0030 .

32. National Center for Infectious Diseases. Chapter of infectious disease physicians of the Academy of Medicine of Singapore. Period of infectivity to inform strategies for de-isolation for COVID-19 patients. Updated 2020. Accessed September 27, 2021. https://www.ams.edu.sg/view-pdf.aspx?file=media%5c5556_fi_331.pdf&ofile=Period+of+Infectivity+Position+Statement+(final)+23-5-20+(logos).pdf .

33. La Scola B, Le Bideau M, Andreani J, Hoang VT, Grimaldier C, Colson P, et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis. 2020; 39(6):1059–1061. PMID: 32342252.

34. Krupp K, Madhivanan P, Perez-Velez CM. Should qualitative RT-PCR be used to determine release from isolation of COVID-19 patients? J Infect. 2020; 81(3):452–482.

35. Lan FY, Wei CF, Hsu YT, Christiani DC, Kales SN. Work-related COVID-19 transmission in six Asian countries/areas: a follow-up study. PLoS One. 2020; 15(5):e0233588. PMID: 32428031.

36. Shreffler J, Petrey J, Huecker M. The impact of COVID-19 on healthcare worker wellness: a scoping review. West J Emerg Med. 2020; 21(5):1059–1066. PMID: 32970555.

37. Park SY, Kim B, Jung DS, Jung SI, Oh WS, Kim SW, et al. Psychological distress among infectious disease physicians during the response to the COVID-19 outbreak in the Republic of Korea. BMC Public Health. 2020; 20(1):1811. PMID: 33246426.

38. Xin H, Li Y, Wu P, Li Z, Lau EHY, Qin Y, et al. Estimating the latent period of coronavirus disease 2019 (COVID-19). Clin Infect Dis. Forthcoming. 2021; DOI: 10.1093/cid/ciab746.

39. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020; 383(27):2603–2615. PMID: 33301246.

40. Thomas SJ, Moreira ED Jr, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine through 6 months. N Engl J Med. 2021; 385(19):1761–1773. PMID: 34525277.